Literature DB >> 18095536

'All that glitters is not gold': misdiagnosis of psychosis in pervasive developmental disorders--a case series.

David R Dossetor1.   

Abstract

The early literature established the validity of the distinction between early onset schizophrenia and autism. In the modern context of increasing recognition of pervasive developmental disorders (PDD) and a growing interest in very early onset schizophrenia and other childhood onset psychoses, this clinical distinction is often difficult to make. This article looks at problems arising from overdiagnosing psychosis in those with PDD. Four case examples of misattributed diagnosis of psychosis are described. The features that were mistaken for psychotic phenomena are described and explained and successfully treated in the context of a diagnosis of PDD. The article describes problems of reliability of ascertaining subjective mental phenomena and the range of mental phenomena that need to be recognized in PDD. The overlap of abnormal perceptions and cognitions in both these conditions is described with reference to the literature. It is evident that more needs to be done to improve diagnostic reliability of psychosis in PDD, by improving clinical awareness and research tools.

Entities:  

Mesh:

Year:  2007        PMID: 18095536     DOI: 10.1177/1359104507078476

Source DB:  PubMed          Journal:  Clin Child Psychol Psychiatry        ISSN: 1359-1045            Impact factor:   2.544


  17 in total

1.  Child Behavior Checklist Scores for School-Aged Children with Autism: Preliminary Evidence of Patterns Suggesting the Need for Referral.

Authors:  Carla A Mazefsky; Ranita Anderson; Caitlin M Conner; Nancy Minshew
Journal:  J Psychopathol Behav Assess       Date:  2011-03

2.  Unremitting impulsive aggression in a child with childhood onset schizophrenia and pervasive development disorder-not otherwise specified: the role of stimulants, atypical antipsychotics and mood stabilizers.

Authors:  Sarper Taskiran; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-06       Impact factor: 2.576

3.  Usability and reliability of a remotely administered adult autism assessment, the autism diagnostic observation schedule (ADOS) module 4.

Authors:  Jamie L Schutte; Michael P McCue; Bambang Parmanto; John McGonigle; Benjamin Handen; Allen Lewis; I Wayan Pulantara; Andi Saptono
Journal:  Telemed J E Health       Date:  2015-01-08       Impact factor: 3.536

4.  A Predictive Coding Account of Psychotic Symptoms in Autism Spectrum Disorder.

Authors:  Gerrit I van Schalkwyk; Fred R Volkmar; Philip R Corlett
Journal:  J Autism Dev Disord       Date:  2017-05

5.  Varieties of misdiagnosis in ASD: an illustrative case series.

Authors:  Gerrit I Van Schalkwyk; Francesco Peluso; Zheala Qayyum; James C McPartland; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2015-04

Review 6.  Pervasive developmental disorders and psychosis.

Authors:  Jean Starling; David Dossetor
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

7.  Experiences of receiving a diagnosis of autism spectrum disorder: a survey of adults in the United kingdom.

Authors:  Lydia Jones; Lorna Goddard; Elisabeth L Hill; Lucy A Henry; Laura Crane
Journal:  J Autism Dev Disord       Date:  2014-12

8.  An investigation of the "jumping to conclusions" data-gathering bias and paranoid thoughts in Asperger syndrome.

Authors:  Claire Jänsch; Dougal Julian Hare
Journal:  J Autism Dev Disord       Date:  2014-01

9.  AUTISM Spectrum Disorders and Suicidality.

Authors:  Michele Raja; Antonella Azzoni; Alessandra Frustaci
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-03-30

10.  Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders.

Authors:  Björn Hofvander; Richard Delorme; Pauline Chaste; Agneta Nydén; Elisabet Wentz; Ola Ståhlberg; Evelyn Herbrecht; Astrid Stopin; Henrik Anckarsäter; Christopher Gillberg; Maria Råstam; Marion Leboyer
Journal:  BMC Psychiatry       Date:  2009-06-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.